Cardiovascular safety of assisted reproductive technology: a meta-analysis
AbstractBackground and Aims. The increasing use of assisted reproductive technology (ART) has raised concerns regarding its long-term cardiovascular safety
Related Articles
Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review
AbstractContext. Germline CDKN1B variants predispose patients to multiple endocrine neoplasia type 4 (MEN4), a rare MEN1-like syndrome, with <100 report
Defensive Medicine in an Emergency Department: The Overuse of High-Sensitivity Cardiac Troponin I Testing
Introduction: Cardiac troponin I is routinely measured in patients with suspected acute coronary syndrome. However, when a high-sensitivity cardiac troponin I (hs-cTnI) test is ordered…
Transient High Salt Intake Promotes T-Cell–Mediated Hypertensive Vascular Injury | Hypertension
BACKGROUND: Dietary high salt (HS) intake has a strong impact on cardiovascular diseases. Here, we investigated the link between HS-aggravated immune responses and the development…
TAVI for pure aortic regurgitation – LIVE case
Explore the clinical burden of pure aortic regurgitation and learn about transcatheter technologies for its management. Discuss techniques to prevent severe aortic regurgitation in complex…
ファーウェイ、心電図機能を対象ウォッチに提供開始 – 血圧測定できる「WATCH D2」は支援額1億円突破
ファーウェイ・ジャパンは1月8日、同社の対象スマートウォッチ製品に向け、心電図測定機能を追加するソフトウェアアップデートを順次提供開始した。約1週間をかけ、専用スマートフォンアプリ「HUAWEI Health」を通じてユーザーにアップデート通知が届く予定。
‘As of my last knowledge update’: How is content generated by ChatGPT infiltrating scientific papers published in premier journals?
The aim of this paper is to highlight the situation whereby content generated by the large language model ChatGPT is appearing in peer-reviewed papers in…
Predatory journals: what can we do to protect their prey?
A growing number of entities misrepresent themselves as scholarly journals for financial gain despite not meeting scholarly publishing standards.1,2 As editors and members of the…
De-escalating and discontinuing disease-modifying therapies in multiple sclerosis
The benefits of early initiation of disease-modifying therapy in multiple sclerosis are well-established; however, the issue of when and how to de-escalate
Age at onset mediates genetic impact on disease severity in facioscapulohumeral muscular dystrophy
FSHD type 1 shows marked variability in age at onset and disease severity. Zheng et al. reveal independent contributions of genetic characteristics, includ